At a glance
ClinicalIndex Comparison RecordN/ACompleted· 50 enrolled
Drug / intervention
Aerobic Exercisebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Role of Exercise in the Prevention and Treatment of RAGE-Mediated Inflammation (RECEPTOR) Trial
In Brief
A clinical study evaluating Aerobic Exercise for Diabetes Mellitus, Type 2. Completed, enrolled 50 participants across 1 site.
Detailed Summary
This study examines the effects of 12-weeks of aerobic exercise training on the mechanisms driving RAGE-mediated inflammation in type 2 diabetic humans.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus, Type 2
CountriesUnited States
Timeline
N/ACompletedFinished
20192020202120222023202420252026
First PostedMay 2018
Enrollment StartDec 2018
Primary CompletionMay 2023
TodayJul 2026
First PostedMay 23, 2018
Enrollment StartDec 20, 2018
Primary CompletionMay 8, 2023
TodayJul 2, 2026
Enrollment to primary: 4.4 yearsPosted 8.1 years ago
Interventions
Aerobic Exercisebehavioral
12-week supervised aerobic exercise